426 related articles for article (PubMed ID: 11890553)
1. The ARTT motif and a unified structural understanding of substrate recognition in ADP-ribosylating bacterial toxins and eukaryotic ADP-ribosyltransferases.
Han S; Tainer JA
Int J Med Microbiol; 2002 Feb; 291(6-7):523-9. PubMed ID: 11890553
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
Han S; Arvai AS; Clancy SB; Tainer JA
J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
[TBL] [Abstract][Full Text] [Related]
3. Three conserved consensus sequences identify the NAD-binding site of ADP-ribosylating enzymes, expressed by eukaryotes, bacteria and T-even bacteriophages.
Domenighini M; Rappuoli R
Mol Microbiol; 1996 Aug; 21(4):667-74. PubMed ID: 8878030
[TBL] [Abstract][Full Text] [Related]
4. Conserved structural motif for recognizing nicotinamide adenine dinucleotide in poly(ADP-ribose) polymerases and ADP-ribosylating toxins: implications for structure-based drug design.
Lee YM; Babu CS; Chen YC; Milcic M; Qu Y; Lim C
J Med Chem; 2010 May; 53(10):4038-49. PubMed ID: 20420408
[TBL] [Abstract][Full Text] [Related]
5. Conformational plasticity is crucial for C3-RhoA complex formation by ARTT-loop.
Tsuge H; Yoshida T; Tsurumura T
Pathog Dis; 2015 Dec; 73(9):ftv094. PubMed ID: 26474844
[TBL] [Abstract][Full Text] [Related]
6. Mouse T cell membrane proteins Rt6-1 and Rt6-2 are arginine/protein mono(ADPribosyl)transferases and share secondary structure motifs with ADP-ribosylating bacterial toxins.
Koch-Nolte F; Petersen D; Balasubramanian S; Haag F; Kahlke D; Willer T; Kastelein R; Bazan F; Thiele HG
J Biol Chem; 1996 Mar; 271(13):7686-93. PubMed ID: 8631807
[TBL] [Abstract][Full Text] [Related]
7. Exchange of glutamine-217 to glutamate of Clostridium limosum exoenzyme C3 turns the asparagine-specific ADP-ribosyltransferase into an arginine-modifying enzyme.
Vogelsgesang M; Aktories K
Biochemistry; 2006 Jan; 45(3):1017-25. PubMed ID: 16411778
[TBL] [Abstract][Full Text] [Related]
8. Substrate N
Yoshida T; Tsuge H
J Biol Chem; 2018 Sep; 293(36):13768-13774. PubMed ID: 30072382
[TBL] [Abstract][Full Text] [Related]
9. Evolution and mechanism from structures of an ADP-ribosylating toxin and NAD complex.
Han S; Craig JA; Putnam CD; Carozzi NB; Tainer JA
Nat Struct Biol; 1999 Oct; 6(10):932-6. PubMed ID: 10504727
[TBL] [Abstract][Full Text] [Related]
10. Common structure of the catalytic sites of mammalian and bacterial toxin ADP-ribosyltransferases.
Okazaki IJ; Moss J
Mol Cell Biochem; 1994 Sep; 138(1-2):177-81. PubMed ID: 7898462
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of threonine ADP-ribosylation of ubiquitin by bacterial ARTs.
Tan J; Xu Y; Wang X; Yan F; Xian W; Liu X; Chen Y; Zhu Y; Zhou Y
Nat Chem Biol; 2024 Apr; 20(4):463-472. PubMed ID: 37945894
[TBL] [Abstract][Full Text] [Related]
12. Structure-function analysis of the Rho-ADP-ribosylating exoenzyme C3stau2 from Staphylococcus aureus.
Wilde C; Just I; Aktories K
Biochemistry; 2002 Feb; 41(5):1539-44. PubMed ID: 11814347
[TBL] [Abstract][Full Text] [Related]
13. Characterization of mammalian ADP-ribosylation cycles.
Okazaki IJ; Zolkiewska A; Takada T; Moss J
Biochimie; 1995; 77(5):319-25. PubMed ID: 8527484
[TBL] [Abstract][Full Text] [Related]
14. Role of glutamic acid 988 of human poly-ADP-ribose polymerase in polymer formation. Evidence for active site similarities to the ADP-ribosylating toxins.
Marsischky GT; Wilson BA; Collier RJ
J Biol Chem; 1995 Feb; 270(7):3247-54. PubMed ID: 7852410
[TBL] [Abstract][Full Text] [Related]
15. Bacterial ADP-ribosylating toxins: molecular structures and signal transducing functions.
Kato I
Microbiol Immunol; 1991; 35(5):349-59. PubMed ID: 1943847
[TBL] [Abstract][Full Text] [Related]
16. Evidence that Arg-295, Glu-378, and Glu-380 are active-site residues of the ADP-ribosyltransferase activity of iota toxin.
Perelle S; Domenighini M; Popoff MR
FEBS Lett; 1996 Oct; 395(2-3):191-4. PubMed ID: 8898093
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel components of NAD-utilizing metabolic pathways and prediction of their biochemical functions.
de Souza RF; Aravind L
Mol Biosyst; 2012 Jun; 8(6):1661-77. PubMed ID: 22399070
[TBL] [Abstract][Full Text] [Related]
18. Substrate-assisted catalysis by PARP10 limits its activity to mono-ADP-ribosylation.
Kleine H; Poreba E; Lesniewicz K; Hassa PO; Hottiger MO; Litchfield DW; Shilton BH; Lüscher B
Mol Cell; 2008 Oct; 32(1):57-69. PubMed ID: 18851833
[TBL] [Abstract][Full Text] [Related]
19. [Structure of ADP-ribosylating enzyme and DNA repair].
Uchida K
Nihon Rinsho; 1993 Nov; 51(11):3051-61. PubMed ID: 8277589
[TBL] [Abstract][Full Text] [Related]
20. Common features of the NAD-binding and catalytic site of ADP-ribosylating toxins.
Domenighini M; Magagnoli C; Pizza M; Rappuoli R
Mol Microbiol; 1994 Oct; 14(1):41-50. PubMed ID: 7830559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
